• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL PROTECTOR P14J; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL PROTECTOR P14J; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515109
Device Problem Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/11/2019
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that leakage occurred between the bd phaseal¿ protector p14j and vial during use while drawing up "3cc of keytruda".The following information was provided by the initial reporter, translated from (b)(6) to english: "when drawing about 3cc of keytruda, hcp confirmed leakage on the glove.It may leaked from between the protector and the vial.".
 
Event Description
It was reported that leakage occurred between the bd phaseal¿ protector p14j and vial during use while drawing up "3cc of keytruda".The following information was provided by the initial reporter, translated from japanese to english: "when drawing about 3cc of keytruda, hcp confrmed leakage on the glove.It may leaked from between the protector and the vial.".
 
Manufacturer Narrative
H.6.Investigation: one sample was returned to our quality team for investigation.The product was evaluated and no damage or defects were observed.Functional testing was performed on the sample, no leak between the protector and vial was identified.While the protector was properly fitted to the vial, it was noted that the needle on the protector was detached from the protector housing.A device history review was performed for lot 1904117, no deviations or non-conformances were identified during the manufacturing process that could have contributed to this issue.Leakage testing is performed for all lots during manufacturing to ensure the quality of the membrane.Based on the investigation results, we are not able to identify a root cause related to our manufacturing process at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL PROTECTOR P14J
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key9526011
MDR Text Key190672090
Report Number3003152976-2019-00883
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 03/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2024
Device Catalogue Number515109
Device Lot Number1904117
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/11/2019
Initial Date FDA Received12/27/2019
Supplement Dates Manufacturer Received12/11/2019
Supplement Dates FDA Received04/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-